EpiPen CEO appears before US lawmakers to defend “sickening” price hikes
September 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen
Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …
GSK appoints Emma Walmsley as first female CEO
September 21, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment
GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
GE Healthcare doubles India investment
September 21, 2016Manufacturing and Production, Research and Development, Sales and Marketing GE Healthcare, India
UK firm GE Healthcare is set to double its investment in India as it aims for revenues of £750 million …
Positive Phase III results for Amgen’s Repatha for coronary artery disease
September 21, 2016Research and Development Amgen, Phase III trial, Repatha
Amgen has announced that its monoclonal antibody Repatha (evolocumab) achieved positive Phase III results for the treatment of coronary artery …
Teva and Regeneron team up for $2.6 billion pain treatment development
September 21, 2016Research and Development, Sales and Marketing Regeneron, Teva, fasinumab, osteoarthritis
Teva and Regeneron have entered an agreement worth up to $2.6 billion to develop and market the latter’s experimental nerve …
AstraZeneca and Microsoft to develop ‘drag and drop’ cancer simulation
September 21, 2016Medical Communications, Research and Development AstraZeneca, Digital Pharma Guide, Microsoft
AstraZeneca has entered into a partnership with tech giant Microsoft to develop a new computerised modelling system which promises to …
Allergan expands NASH portfolio with $1.7 billion in acquisitions
September 21, 2016Research and Development, Sales and Marketing Akarna Therapeutics, Allergan, Tobira Therapeutics, acqusition, nash
Allergan has gone on a spending spree this week, snapping up clinical-stage biotech Tobira Therapeutics and privately-held Akarna Therapeutics for …
Sanofi reveals promising data for relapsing remitting MS treatment
September 20, 2016Manufacturing and Production, Research and Development RRMS, Sanofi, relapsing remitting multiple sclerosis, relapsing-remitting multiple sclerosis
Sanofi Genzyme, the speciality care global business unit of the French pharma firm announced six-year investigational data on Lemtrada (alemtuzumab) …
Bayer CEO defends $66 billion Monsanto acquisition
September 20, 2016Manufacturing and Production, Sales and Marketing Bayer, Werner Baumann, monsanto
Bayer AG’s chief executive Werner Baumann has spoken in defence of the company’s move last week to acquire US agricultural …
Takeda partners with Zydus to develop chikungunya vaccine
September 20, 2016Manufacturing and Production, Research and Development Takeda, Zydus Cadila, chikungunya
Zydus Cadila has teamed up with Takeda to develop a vaccine for the chikungunya virus. Zydus Cadila’s group firm Cadila …
GSK appoints Emma Walmsley as CEO
September 20, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, appointment
GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
Duchenne drug gets FDA approval in “unprecedented” ruling
September 20, 2016Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, FDA, sarepta
The FDA has gone against the advice of its own staff to approve the first treatment of Duchenne muscular dystrophy …
PCI Pharma Services to Share Expertise at Free Serialization Forum
September 19, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI Pharma Services
Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Xytnek, Antares, and Healthcare Packaging magazine, will host a …
Ashfield and Patient Connect Form Alliance to Provide Holistic Patient Services
September 19, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield
Ashfield Commercial and Medical Services, part of UDG Healthcare plc, a global leader in providing outsourced healthcare services to pharmaceutical, …
NICE rejects expanded treatment indication for Roche’s Esbriet
September 19, 2016Sales and Marketing Esbriet, NICE, Roche, rejection
NICE has published a final appraisal rejecting the expanded use of Roche’s Esbriet (pirfenidone) for the treatment of early idiopathic …
EU recommendation for Lilly’s soft tissue cancer drug
September 19, 2016Sales and Marketing CHMP, EMA, Eli Lilly, Lartruvo, soft tissue sarcoma
The Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Lartruvo (olaratumab) for treatment of adults with …
J&J in $4.33bn eye surgery unit acquisition
September 19, 2016Manufacturing and Production, Sales and Marketing Abbott, Johnson & Johnson, acquisition
Johnson & Johnson has agreed to buy Abbott Laboratories’ eye surgery equipment unit in an all-cash deal for £4.33 billion …
“First of its kind” manufacturing campus to bring 500 jobs to Ireland
September 19, 2016Manufacturing and Production, Sales and Marketing GE Healthcare, Ireland, manufacturing
Biopharma firm GE Healthcare has made a major investment to create a ‘BioPark’ in Ringaskiddy, Ireland, set to generate 500 …
Sanofi accuses MSD of US patent infringement
September 19, 2016Sales and Marketing MSD, Sanofi, lawsuit
Sanofi has filed a suit against MSD in the United States District Court for the District of Delaware accusing the …
Precision medicine reveals ‘Achilles heel’ in chronic myeloid leukaemia
September 16, 2016Medical Communications University of Glasgow, chronic myeloid leukaemia
Scientists at the University of Glasgow believe they have revealed an ‘Achilles heel’ of chronic myeloid leukaemia (CML), making their …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
